Literature DB >> 1958431

Spontaneous reporting: how many cases are required to trigger a warning?

P Tubert1, B Bégaud, F Haramburu, J C Péré.   

Abstract

A statistical method is proposed to aid decisions on the recognition of new adverse drug reactions on the basis of spontaneous reports. The maximal number of associations between drug exposure and event is calculated from an independence test between drug and event, taking into account the expected incidence of that particular event in the general population. An example is given which illustrates the method.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958431      PMCID: PMC1368597          DOI: 10.1111/j.1365-2125.1991.tb03922.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

Review 1.  Quantitative methods in pharmacovigilance: focus on signal detection.

Authors:  Manfred Hauben; Xiaofeng Zhou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  Implementation of an automated signal detection method in the French pharmacovigilance database: a feasibility study.

Authors:  Véronique Pizzoglio; Ismaïl Ahmed; Pascal Auriche; Pascale Tuber-Bitter; Françoise Haramburu; Carmen Kreft-Jaïs; Ghada Miremont-Salamé
Journal:  Eur J Clin Pharmacol       Date:  2011-12-06       Impact factor: 2.953

3.  Spontaneous reporting of suspected adverse drug reactions.

Authors:  A H Watt
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

4.  Assessment of the risk of fragrance allergy in the general population: challenges and methodological issues.

Authors:  Luigi Naldi
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 5.  Postmarketing surveillance of quinolones, 1990 to 1992.

Authors:  P Davey; T McDonald
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 6.  False-positives in spontaneous reporting: should we worry about them?

Authors:  B Begaud; Y Moride; P Tubert-Bitter; A Chaslerie; F Haramburu
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

7.  Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?

Authors:  Amélie Daveluy; Brigitte Milpied; Annick Barbaud; Bénédicte Lebrun-Vignes; Aurore Gouraud; Marie-Laure Laroche; Ecaterina Ciobanu; Bernard Bégaud; Nicholas Moore; Ghada Miremont-Salamé; Françoise Haramburu
Journal:  Eur J Clin Pharmacol       Date:  2011-07-27       Impact factor: 2.953

8.  The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist.

Authors:  Nicholas Moore
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

9.  Estimating time-to-onset of adverse drug reactions from spontaneous reporting databases.

Authors:  Fanny Leroy; Jean-Yves Dauxois; Hélène Théophile; Françoise Haramburu; Pascale Tubert-Bitter
Journal:  BMC Med Res Methodol       Date:  2014-02-03       Impact factor: 4.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.